...
首页> 外文期刊>Oxidative Medicine and Cellular Longevity >Downregulation of MicroRNA-206 Alleviates the Sublethal Oxidative Stress-Induced Premature Senescence and Dysfunction in Mesenchymal Stem Cells via Targeting Alpl
【24h】

Downregulation of MicroRNA-206 Alleviates the Sublethal Oxidative Stress-Induced Premature Senescence and Dysfunction in Mesenchymal Stem Cells via Targeting Alpl

机译:MicroRNA-206的下调减轻了通过靶向ALPL来减轻了止吐氧化胁迫诱导的过早性衰老和间充质干细胞的功能障碍

获取原文
           

摘要

Bone marrow-derived mesenchymal stem cells (MSCs) have shown great promise in tissue engineering and regenerative medicine; however, the regenerative capacity of senescent MSCs is greatly reduced, thus exhibiting limited therapy potential. Previous studies uncovered that microRNA-206 (miR-206) could largely regulate cell functions, including cell proliferation, survival, and apoptosis, but whether miR-206 is involved in the senescent process of MSCs remains unknown. In this study, we mainly elucidated the effects of miR-206 on MSC senescence and the underlying mechanism. We discovered that miR-206 was upregulated in the senescent MSCs induced by H2O2, and abrogation of miR-206 could alleviate this tendency. Besides, we determined that by targeting Alpl, miR-206 could ameliorate the impaired migration and paracrine function in MSCs reduced by H2O2. In vivo study, we revealed that inhibition of miR-206 in senescent MSCs could effectively protect their potential for myocardial infarction treatment in a rat MI model. In summary, we examined that inhibition of miR-206 in MSCs can alleviate H2O2-induced senescence and dysfunction, thus protecting its therapeutic potential.
机译:骨髓衍生的间充质干细胞(MSCs)在组织工程和再生医学中表现出良好的希望;然而,衰老MSCs的再生能力大大减少,从而表现出有限的治疗潜力。以前的研究发现,MicroRNA-206(miR-206)可以大大调节细胞功能,包括细胞增殖,存活和凋亡,但MiR-206是否参与MSC的衰老过程仍然未知。在这项研究中,我们主要阐明miR-206对MSC衰老和潜在机制的影响。我们发现MIR-206在H 2 O 2诱导的衰老MSC中上调,并且MIR-206的废除可以缓解这种趋势。此外,我们确定通过靶向ALPL,MIR-206可以改善MSC的损伤的迁移和旁静脉功能,降低了H2O2。在体内研究中,我们揭示了衰老MSCS MIR-206的抑制可以有效地保护其对大鼠MI模型中心肌梗塞治疗的潜力。总之,我们检查了MSCS中miR-206的抑制可以缓解H2O2诱导的衰老和功能障碍,从而保护其治疗潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号